Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 34,000 shares at $157.40 ($5.3M) on 2021-10-12, disclosed to the SEC on 2021-10-14.
Open-market sale of $5.3M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.49 | 5,960 | $933K | 17.4% |
| 2 | $156.49 | 5,960 | $933K | 17.4% |
| 3 | $157.40 | 7,997 | $1.3M | 23.5% |
| 4 | $157.40 | 7,997 | $1.3M | 23.5% |
| 5 | $158.63 | 3,043 | $483K | 9.0% |
| 6 | $158.63 | 3,043 |
| $483K |
| 9.0% |
| Total | $157.30 avg | 34,000 | $5.3M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |